{"id":"W2787266690","doi":"10.1016/j.ygyno.2018.01.019","title":"Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"Astellas Pharma","keywords":"Medicine; Paclitaxel; Tolerability; Internal medicine; Clinical endpoint; Ovarian cancer; Adverse effect; Oncology; Discontinuation; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Progression-free survival; Urology; Phases of clinical research; Gastroenterology; Cancer; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008404196,0.0003047365,0.0008205144,0.000214259,0.0001658498,0.00002448698,0.00009188151,0.000232451,0.0001409945],"category_scores_gemma":[0.0007632043,0.0002180709,0.00003118909,0.0002233391,0.0003652077,0.00009666745,0.0001573305,0.0004396872,0.000009108625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003157851,"about_ca_system_score_gemma":0.0002840649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002157457,"about_ca_topic_score_gemma":0.0009187389,"domain_scores_codex":[0.9975078,0.0003675968,0.0006746189,0.0006541506,0.0002765773,0.0005192978],"domain_scores_gemma":[0.9985101,0.0003889193,0.0003135921,0.0002487893,0.0003133403,0.0002252268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008786347,0.005050383,0.7537277,0.00003923317,0.000147392,0.0001746647,0.004093808,1.711995e-7,0.001270729,0.00002491464,0.0002566804,0.2264279],"study_design_scores_gemma":[0.03171826,0.1315563,0.8329652,0.00007758262,0.0002105769,0.00001114237,0.002126781,0.0001125573,0.00005252656,0.00005933908,0.0008854529,0.0002243223],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955004,0.0001779245,0.000006165182,0.0007287325,0.0005058122,0.002012444,0.00004743876,0.00004715152,0.0009738749],"genre_scores_gemma":[0.998239,0.00003755771,0.0005930035,0.0006116452,0.000201834,0.0001785815,0.00002698977,0.00002522536,0.00008611097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2262036,"threshold_uncertainty_score":0.8892675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0326541113957711,"score_gpt":0.3527039054452852,"score_spread":0.3200497940495141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}